Emmessar Biotech Q2 FY27 Financial Results
Emmessar Biotech & Nutrition Ltd · Others (Uncategorized) · 02 Nov 2026, 8:36 pm
Emmessar Biotech Q2 FY27 Financial Results Emmessar Biotech & Nutrition published its unaudited financial results for the quarter ended 30th Sep'26. Total revenue reached ₹62.50 lakh, compared to ₹59.85 lakh in Q1 FY27 and ₹63.04 lakh in Q2 FY26. Total expenses stood at ₹45.24 lakh versus ₹43.55 lakh in the preceding quarter. Net profit after tax came in at ₹14.03 lakh, up slightly from ₹13.15 lakh in Q1 FY27 and ₹11.46 lakh in Q2 FY26. Basic and diluted EPS for the quarter was reported at ₹0.28.
Original exchange filing (PDF)
More announcements from Emmessar Biotech & Nutrition Ltd
- Please refer attachment · 31 Oct 2026
- Please refer attachment. · 31 Oct 2026
- Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Please refer attachment · 31 Oct 2026
- Please refer attachment · 02 Oct 2026
- Please refer attachement · 29 Sept 2026
- Please refer attachment · 29 Sept 2026
- Please refer attachment · 05 Sept 2026
- Please refer attachment · 04 Sept 2026
